Eye on FDA: What Companies Should Do Between Now and The Part 15 Hearing on Social Media
Eye on FDA: What Companies Should Do Between Now and The Part 15 Hearing on Social Media
A good read all the way through. He has advice for individual companies and for industry associations. And this:
At the FDLI conference held earlier this week in Washington, both Dr. Janet Woodcock and Tom Abrams affirmed that this is a priority for FDA. The scheduling of this meeting is a two-sided coin – on the one hand, there is a tremendous opportunity to help shape policy around the way industry and consumers can communicate; on the other hand, done badly, it will create yet one more obstacle not only for better marketing and bringing industry into an arena where patients are seeking more healthcare information than any other source, and may even result in the unintended consequence of impairing rather than supporting public health.
